Risk of complications and mortality following recurrent and non-recurrent Clostridioides difficile infection: a retrospective observational database study in England

被引:25
作者
Enoch, D. A. [1 ]
Murray-Thomas, T. [2 ]
Adomakoh, N. [3 ]
Dedman, D. [2 ]
Georgopali, A. [3 ]
Francis, N. A. [4 ,5 ]
Karas, A. [3 ]
机构
[1] Addenbrookes Hosp, Publ Hlth England, Cambridge, England
[2] Clin Practice Res Datalink, London, England
[3] Astellas Pharma Europe Ltd, Addlestone, Surrey, England
[4] Cardiff Univ, Div Populat Med, Cardiff, Wales
[5] Univ Southampton, Sch Primary Care, Populat Sci & Med Educ, Southampton, Hants, England
关键词
Clostridioides difficile; infection; Recurrence; Mortality; Complications; CLINICAL-PRACTICE GUIDELINES; HEALTH-CARE EPIDEMIOLOGY; HOSPITALIZED-PATIENTS; DISEASES SOCIETY; ECONOMIC BURDEN; UPDATE; ADULTS; FIDAXOMICIN; DIARRHEA; IMPACT;
D O I
10.1016/j.jhin.2020.09.025
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Clostridioides difficile infection (CDI) increases the risk of complications and mortality. We assessed the magnitude of these outcomes in a large cohort of English patients with initial and recurrent CDI. Aim: To compare the risk of complications and all-cause mortality, within 12 months, among hospitalized patients >18 years old with hospital-associated(HA-) CDI and recurrent CDI. Methods: Patients with HA-CDI during 2002-2013 were identified using inpatient hospital data linked to primary care and death data. Each HA-CDI case was frequency matched to two hospitalized patients without CDI on age group, sex, calendar year of admission, admission method and number of hospital care episodes. A second CDI episode starting on days 13-56 was defined as recurrence. Risks of mortality and complications at 12 months were analysed using Cox proportional hazard models. Findings: We included 6862 patients with HA-CDI and 13,724 without CDI. Median age was 81.0 years (IQR 71.0-87.0). Patients with HA-CDI had more comorbidities than those without CDI, and significantly higher risks of mortality (adjusted hazard ratio (95% confidence interval) 1.77 (1.67-1.87)) and complications (1.66 (1.46-1.88)) within 12 months from hospital admission. Of those with HA-CDI, 1140 (16.6%) experienced CDI recurrence. Patients with recurrent versus non-recurrent CDI also had significantly increased risk of mortality (1.32 (1.20-1.45)) and complications (1.37 (1.01-1.84)) in the 12 months from the initial CDI. Conclusions: HA-CDI (versus no CDI) and recurrent CDI are both associated with significantly higher risks of complications or death within 12 months of the initial CDI episode. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
引用
收藏
页码:793 / 803
页数:11
相关论文
共 48 条
[1]   Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients [J].
Abdelfatah, Mohamed ;
Nayfe, Rabih ;
Nijim, Ala ;
Enriquez, Kathleen ;
Ali, Eslam ;
Watkins, Richard R. ;
Kandil, Hossam .
JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (05) :747-751
[2]   Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review [J].
Abou Chakra, Claire Nour ;
Pepin, Jacques ;
Sirard, Stephanie ;
Valiquette, Louis .
PLOS ONE, 2014, 9 (06)
[3]   Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus [J].
Asha, N. J. ;
Tompkins, D. ;
Wilcox, M. H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2006, 44 (08) :2785-2791
[4]   Trends in mortality following Clostridium difficile infection in Scotland, 2010-2016: a retrospective cohort and case-control study [J].
Banks, A. ;
Moore, E. K. ;
Bishop, J. ;
Coia, J. E. ;
Brown, D. ;
Mather, H. ;
Wiuff, C. .
JOURNAL OF HOSPITAL INFECTION, 2018, 100 (02) :133-141
[5]   Excess mortality between 2007 and 2014 among patients with Clostridium difficile infection: a French health insurance database analysis [J].
Barbut, F. ;
Bouee, S. ;
Longepierre, L. ;
Goldberg, M. ;
Bensoussan, C. ;
Levy-Bachelot, L. .
JOURNAL OF HOSPITAL INFECTION, 2018, 98 (01) :21-28
[6]   Clinical recognition and diagnosis of Clostridium difficile infection [J].
Bartlett, John G. ;
Gerding, Dale N. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 :S12-S18
[7]   Clostridium difficile infection in Europe: a hospital-based survey [J].
Bauer, Martijn P. ;
Notermans, Daan W. ;
van Benthem, Birgit H. B. ;
Brazier, Jon S. ;
Wilcox, Mark H. ;
Rupnik, Maja ;
Monnet, Dominique L. ;
van Dissel, Jaap T. ;
Kuijper, Ed J. .
LANCET, 2011, 377 (9759) :63-73
[8]   Consequences of Clostridium difficile infection: understanding the healthcare burden [J].
Bouza, E. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 :5-12
[9]   Impact of malignancy on Clostridium difficile infection [J].
Chung, M. S. ;
Kim, J. ;
Kang, J. O. ;
Pai, H. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (11) :1771-1776
[10]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455